SCHEMBL9759896

SCHEMBL9759896

O=C(c1ccccc1)c1ccc2[nH]c(=O)[nH]c(=O)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.51
CA9 Q16790 2/20 0.51
PARP1 P09874 2/20 0.51
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 4/20 0.48
RAB9A P51151 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
POLB P06746 2/20 0.48
HTT P42858 2/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
ATM Q13315 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
BRD4 O60885 1/20 0.45
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ABL1 P00519 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7033202 0.83 KDM4E (0.56) CA12CA9PARP1KDM4EALDH1A1
SCHEMBL24576213 0.83 MEN1 (0.64) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL11069044 0.79 ALDH1A1 (0.57) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL7023220 0.77 LIMK1 (0.55) CA12CA9PARP1KDM4EALDH1A1
SCHEMBL11947173 0.76 MEN1 (0.60) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL13780270 0.75 KDM4E (0.62) PARP1KDM4EALDH1A1RAB9AMEN1
SCHEMBL9760930 0.74 ADORA3 (0.56) CA12CA9KDM4EALDH1A1RAB9A
SCHEMBL11412012 0.73 ATM (0.53) PARP1KDM4EALDH1A1RAB9AMEN1
SCHEMBL8900615 0.73 PDE3A (0.62) CA12CA9PARP1KDM4EALDH1A1
SCHEMBL29152717 0.73 ATM (0.57) PARP1KDM4EALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5037829-A Antitumor Activity; Androgen, Estrogen Inhibitors; Suppress The Plasma Elimination Of Retinoids JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-06 US disclosed